Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2008 Financial Results
Date:10/30/2008

ich we continue to estimate will be

approximately $3.5 to $4.5 million. We have been tracking to the high

end of our SG&A guidance due to increased legal expenses.

-- We anticipate that our 2008 interest expense will be approximately $6 to

$7 million. Included in those costs is $3.5 to $4 million of interest

expense on our debt agreements and $2.5 to $3 million of non-cash

amortization costs related to our embedded derivative and debt discount

on both our old convertible notes and our new credit facility.

-- We expect to end 2008 with a cash balance of $25 to $35 million,

depending upon fluctuations in working capital.

Conference Call

ISTA will host a conference call with a simultaneous webcast, today October 30, 2008, at 10:00 AM Eastern Time, to discuss its third quarter 2008 results. To access the live conference call, U.S. and Canadian participants may dial 800-260-8140; international participants may dial 617-614-3672. The access code for the live call is 73172859. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 20163809. The conference call will also be webcast live and archived on ISTA's website for 30 days at http://www.istavision.com.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby cont
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
2. Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference and Webcast
3. PUR Water Filtration Systems Can Remove Pharmaceuticals Identified in U.S. Tap Water - More Than 99 Percent for PUR Faucet Filters and More Than 96 Percent for PUR Pitchers*
4. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
5. Watson Pharmaceuticals Reports Third Quarter 2008 Results
6. Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences
7. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R)
10. Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
11. CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together by ... up to 30lbs in less than 12 weeks without traditional ... prompting an investigative review. , “Our Incredible Bulk review ... that allows the body to pack on a massive amount ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and easy ... treat specific body parts and muscle groups. , IsoComforter, ... use patented cold therapy machine with the innovative IsoTube design ... injuries. IsoComforter has become the industry leader in cold ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for ... its latest collection of wedding dresses , and launches ... is the wedding dress on your big day; the wedding ... Every bride wants to find the most suitable wedding dress. ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... moderation offers no harm to an expectant mother, in terms ... ,This study performed by researcher Dr Bodil Hammer Bech and ... online by the British Medical Journal. , ... commencing before 20 weeks into their pregnancy. ,The ...
... owners are at a greater risk of catching bird flu, as ... say.// ,A study on cats in areas where outbreaks ... quickly than thought. It raises the chilling prospect that the disease ... a human pandemic. And it shows that should bird flu ever ...
... predictions about bird flu, involving the use of a ... drugs might be the best way to deal with ... influenza) has not triggered a worldwide human epidemic yet ... acquire this ability, it would take 6-8 months to ...
... bronchitis and other acute respiratory infections in Afghanistan // following ... health agency is sending antibiotics for thousands of people and ... catching the illnesses. ,“Early recognition and prompt ... spokesman Adrian Edwards told a press briefing in Kabul, the ...
... steroids can inhibit joint damage when used in the early ... evidence.// ,High-quality evidence supports combining the pills ... “Such treatment should be made readily available to patients,” say ... in England. ,Concern exists about the side ...
... face a significantly high risk of getting cancer once ... than 10 percent of these men ultimately developed second ... skin. Hence the researchers recommend that a close monitoring ... cancer in them. ,Hoda Anton-Culver, Sacha Satram-Hoang ...
Cached Medicine News:Health News:Coffee Addicts With Baby, Take Heart 2Health News:Cat Owners at Risk of Bird Flu 2Health News:UN Sends Medicine to Afghanistan 2Health News:Low-Dose Steroids Reduce Joint Damage From Rheumatoid Arthritis 2Health News:Low-Dose Steroids Reduce Joint Damage From Rheumatoid Arthritis 3Health News:Breast Cancer in Men Lead to Second Primary Cancers 2
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... focus on Omega-3 therapies for cardiovascular disease and overall health ... Company,s accomplishments in 2014 and its outlook for 2015 from ... Fellow Shareholders, We would like to take this ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Infectious Disease Diagnostics Market by Product, Application, Technology, ... to their offering. , The infectious disease ... 7.9% to reach $18,156.2 million by 2019 from $12,422.8 ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... 5, 2012  EntreMed, Inc. (Nasdaq: ENMD ), ... of cancer, announced today that it has initiated plans ... Company,s drug development and clinical trials in that country.  ... terminated their agreement regarding SVT,s right to enter into ...
... 5, 2012 FUJIFILM Medical Systems U.S.A., Inc. today announced ... received modular electronic health record (EHR) certification for Meaningful Use ... within the American Recovery and Reinvestment Act (ARRA) of 2009, ... use certified EHRs and show that they use them in ...
Cached Medicine Technology:EntreMed Initiates Plans for China Office 2EntreMed Initiates Plans for China Office 3EntreMed Initiates Plans for China Office 4FUJIFILM Receives Modular EHR Certification for Meaningful Use for Radiology 2FUJIFILM Receives Modular EHR Certification for Meaningful Use for Radiology 3
... The TLC Self-Retaining Retractor System has ... retract and secure the delicate soft tissue ... the surgeon to perform the procedure without ... give the surgical assistant the freedom to ...
... System is a revolutionary new addition to ... instruments. The PowerPro Battery System is the ... instrument available on the market. It is ... to meet the requirements of large bone, ...
Stryker Instruments, the leader in cordless power, advances orthopaedics with the power, speed, versatility, reliability and performance through its heavy duty powered instruments....
... A quality mini ... that features a selective ... of view. XiScan mini ... friendly intra-operative imaging systems ...
Medicine Products: